teriaceae. Specifically, the pertussis endotoxin contains a lipid A moiety covalently linked to an oligosaccharide core but lacks the long polysaccharide 0-specific chains (2, 3, 10, 17) . The LOS of B. pertussis exhibits biological activities similar to those of endotoxins from other gram-negative bacteria, including pyrogenicity, toxicity, induction of the Shwartzman reaction, induction of tumor necrosis factor production, and adjuvant properties (7, 17, 21, 27, 34, 36 In a previous report, we described seven monoclonal antibodies (MAbs) specific for a surface-accessible epitope(s) present on the B. pertussis LOS A band (4). In the
Several Bordetella pertussis virulence determinants, such as the pertussis toxin, adenylate cyclase toxin, and filamentous hemagglutinin, are regulated by a single genetic locus named vir, or bvg (5, 38) . The virulence determinants of the other two virulent species, Bordetella parapertussis and Bordetella bronchiseptica, are also under the control of a similar regulatory locus (26) . Strains which are unable to express these virulence factors are also unable to cause whooping cough (37) . The virulent phenotype (Vir+) is unstable and can give rise to phase variants, a genetic event which occurs at a frequency of i0' to , such that variants no longer stably express any of the virulenceassociated genes in any environment (32, 35) . A second type of variation, called phenotypic modulation, also results in the reversible loss of certain virulence factors and is dependent on changes in the environment such as temperature and the presence of magnesium sulfate or nicotinic acid (25) . Modifications of surface components such as outer membrane (OM) proteins and lipooligosaccharide (LOS) have also been described for these variant strains (6) .
The B. pertussis LOS possesses a chemical structure different from that of the well-known lipopolysaccharides (LPS) of smooth-type members of the family Enterobac-* Corresponding author.
teriaceae. Specifically, the pertussis endotoxin contains a lipid A moiety covalently linked to an oligosaccharide core but lacks the long polysaccharide 0-specific chains (2, 3, 10, 17) . The LOS of B. pertussis exhibits biological activities similar to those of endotoxins from other gram-negative bacteria, including pyrogenicity, toxicity, induction of the Shwartzman reaction, induction of tumor necrosis factor production, and adjuvant properties (7, 17, 21, 27, 34, 36) . Previous analysis of pertussis endotoxin by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western immunoblotting identified two distinct LOS components, a slowly migrating major band and a fast-migrating minor band, designated A and B bands, respectively (28) . Subsequently, on the basis of their LOS profiles, B. pertussis strains were classified into two physiologically and serologically distinct phenotypes: the LOS wild-type phenotype possessing both the A and B bands and the LOS variant phenotype possessing only the B band. Caroff et al. (10) have suggested that LOS B of variant LOS B strains is identical to the LOS B component of endotoxin from LOS AB wild-type strains. In fact, they have demonstrated that the carbohydrate regions of LOS B variant strains lack three amino sugars present in LOS A of the wild-type strains.
In a previous report, we described seven monoclonal antibodies (MAbs) specific for a surface-accessible epitope(s) present on the B. pertussis LOS A band (4 (9) . Protein concentrations were determined by the Lowry method adapted to membrane fractions (19) . Purified LOS from B. pertussis 134 was obtained by the phenol-water extraction procedure described by Inzana (14) .
Immunization of mice and fusion procedure. BALB/c mice, 6 to Hybridomas were produced by fusion of spleen cells recovered from immunized animals with the nonsecreting SP2/O myeloma cells as described elsewhere (12) . Hybrid clone supernatants were tested for antibody production by enzyme-linked immunosorbent assay (ELISA), as previously described (12) , by using OM from the B. pertussis 134 LOS B variant strain as the coating antigen (7.5 ,ug Western immunoblotting procedure. For Western blot experiments, the bacterial preparations containing the LOSs were prepared by following one of two methods. In the first method, the bacterial concentrations were carefully adjusted to obtain a semiquantitative evaluation of the amount of LOS. BGA-grown organisms were collected, suspended in PBS (pH 7.2), and spectrophotometrically adjusted to an optical density of 2.5 (A = 490 nm). Fifty microliters of a 10% (wt/vol) solution of SDS (Bio-Rad Laboratories, Richmond, Calif.) was added to 500 ,ul of the bacterial suspension. Each preparation was boiled for 10 min and centrifuged for 10 min in a microcentrifuge to remove the cellular debris. This step was repeated once. In the second method, purified LOS was obtained after enzymatic digestion of whole bacterial cells. BGA-grown organisms were treated with 1 mg of proteinase K (Sigma Chemical Co., St. Louis, Mo.) per ml for 3 h at 56°C with agitation. These bacterial preparations were then centrifuged at 3,000 x g for 10 min to remove the undigested cellular fragments. Two volumes of cold acetone (BDH Inc., Toronto, Ontario, Canada) was added to the supernatants and incubated at -20°C for 5 min. The resulting precipitate was collected by centrifugation at 3,000 x g for 10 min, and the pellet was suspended in distilled water. All bacterial preparations were resolved by electrophoresis by using the discontinuous buffer system of Laemmli (16) with 18% (wt/vol) gels, and Western blot analysis were performed as previously described (23) . The silver stain method of Tsai and Frasch was used to visualize the LOS (33 (Fig. 1B) . MAb BL-2 also recognized an LPS band present on both the Vir+ and Vir-phenotypic variant strains of B. bronchiseptica (Fig.  2B) , with stronger reactions always noted against the three Vir+ variant strains. In contrast, MAb BL-8 recognized the LOS B band expressed by the three B. pertussis strains and their corresponding isogenic phenotypic variants (Fig. 1C) . However, in this case weaker reactivity of MAb BL-8 for the Vir+ phenotypic variants of strains Tohama 1 and 3779 in comparison to the Vir-variants was observed. Silver staining of duplicate gels indicated that the Vir+ phenotypic variant strains expressed less of the LOS B band even when an equivalent number of bacterial cells were used. As indicated by the Western blot and silver stain results, there is not a comparable difference in the amount of LOS B for the different phenotypic variants of the LOS B strain 134.
MAb BL-8 also reacted with an LPS band present in the preparations obtained from the Vir-variant strains of B. bronchiseptica (Fig. 2C) . Compared with the LPS band recognized by MAb BL-2, this band has a slightly lower molecular weight. Results similar to the ones already described for MAb BL-8 were also recorded for MAb (data not shown).
The reactivities of these three MAbs with proteinase K-treated bacterial preparations of additional strains were evaluated, and the results are summarized in Table 1 
- (1) - (1) - (3) - ( c + +, More than 10,000 cpm; +, between 5,000 and 10,000 cpm; ±, between 500 and 5,000 cpm; -, less than 500 cpm. (Fig. 3B) . In contrast, the epitope recognized by MAb BL-8 is readily accessible on the surface of the LOS B strain 134 and its Vir-phenotypic variants as well as on the surface of the Vir-phenotypic variants of the LOS AB strains Tohama 1 and 3779 (Fig. 3A) . Lower (Fig. 3B ). Additional strains were tested by using the accessibility assay, and the results are presented in (17) reported no differences in the endotoxin composition from any serological phase of B. pertussis. Recently we have developed MAbs, rather than conventional polyvalent antisera, in order to precisely identify the B-cell epitopes present on the surface of bacterial cells. We have described several human and murine MAbs which are directed against carbohydrate epitope(s) on the B. pertussis LOS A (4, 8) . In this article, we present the characterization of two MAbs that are specific for the LOS B band.
Three immunological assays were used to study the epitope(s) identified by the LOS B-specific MAbs BL-8 and BL-9. First, a dot enzyme immunoassay was used to rapidly evaluate the reactivities of the MAbs against a large panel of strains (4, 8, 20, 22) . In the second assay, each of the bacterial cell components was resolved by using SDS-PAGE followed by Western immunoblotting. Under these conditions, the reactivities of the MAbs were completely independent of the cell surface exposure of the epitopes and of their relationship with other cell surface components. The third test, the radioimmunobinding assay, was designed to identify only those epitopes present on the surface of intact bacterial cells. By using this latter assay, we have previously been able to discriminate between epitopes of Haemophilus influenzae type b OM protein that were deeply embedded inside the membrane versus those easily accessible on the surface of intact bacteria (24, 30) . The LOS-specific MAbs and the three immunological tests were used to study the relationships between the type, amount, and exposure of LOS expressed by a B. pertussis strain and its isogenic phenotype variants.
It has been shown previously that all B. pertussis strains express an LOS B band (28) . We thus anticipated that, in the dot immunoassay, the B band-specific MAbs would recognize all the B. pertussis strains regardless of the phase or the LOS phenotype. To our surprise, we found that MAbs BL-8 and BL-9 reacted strongly only with the LOS B variant strains and certain laboratory LOS AB strains and did not recognize any B. pertussis clinical strains (Table 1 (2, 4, 18, 31) . In this study, on the basis of Western immunoblotting, the epitope(s) recognized by MAbs BL-8 and BL-9 was shown to be expressed by B. bronchiseptica Vir-variant strains but not by Vir+ organisms. This suggests that expression of Bordetella endotoxin may be regulated in part by the vir locus, as are other virulence determinants (26) . Moreover, it identifies a cross-reactive epitope located on the B bands of both B. pertussis and B. bronchiseptica endotoxins. However, as shown by the accessibility studies, the epitope recognized by the LOS B-specific MAbs is not exposed at the surface of intact B. bronchiseptica cells. Conversely, the LOS-specific MAbs did not crossreact with the LPS of B. parapertussis, corroborating results of other studies which indicated that the LPS of B. parapertussis was antigenically distinct from the LOS of B. pertussis (2, 4, 31) .
It is well established that the LOS of B. pertussis can elicit the production of bactericidal antibodies (1, 4, 8, 11) . The bactericidal activities of MAbs BL-8 and BL-9 against two B. pertussis strains, the LOS AB strain 9340 and the LOS B variant strain 134, were evaluated ( In the present studies, MAb BL-9 was not bacteriolytic against the LOS B variant strain. We believe this might be due to the fact that BL-9 is an IgA, an isotype that does not fix serum complement (13) .
In summary, the results presented in this article indicate that the epitope(s) recognized by two LOS B-specific MAbs is conserved in all B. pertussis strains and B. bronchiseptica Vir-phenotypic variant strains tested. Furthermore, the amount of LOS present in the OM seems to be dependent on the virulence-associated or LOS phenotype expressed by each strain. To clarify this relationship and to define the effect of the interaction of other surface molecules on the accessibility of LOS B, we are presently evaluating the reactivities of our MAbs with several mutant B. pertussis strains.
